Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

X Xie, J Lee, T Iwase, M Kai… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Triple-negative breast cancer (TNBC) is the most fatal molecular subtype of
breast cancer because of its aggressiveness and resistance to chemotherapy. FDA …
被引用次数：4 相关文章

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

X Xie, J Lee, T Iwase, M Kai… - Expert opinion on …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Triple-negative breast cancer (TNBC) is the most fatal molecular subtype of
breast cancer because of its aggressiveness and resistance to chemotherapy. FDA …

Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape

X Xie, J Lee, T Iwase, M Kai… - Expert Opinion on …, 2022 - mdanderson.elsevierpure.com
Introduction: Triple-negative breast cancer (TNBC) is the most fatal molecular subtype of
breast cancer because of its aggressiveness and resistance to chemotherapy. FDA …